Microfluidic GBM Assay Platform With Perfusive Immune Cell Flow
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for glioblastoma multiforme (GBM) are ineffective, and there is a lack of in vitro platforms to study GBM-immune cell interactions, hindering the development of immunotherapies.
Innovation Solution
A microfluidic assay device with a flow channel, reservoirs, and barriers that mimic in vivo conditions, allowing for perfusive flow and realistic interactions between T-cells and GBM tumor cultures, enabling the study of GBM-immune cell interactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional in vitro platforms are used to study GBM-immune cell interactions, then the platform structure is simple, but the ability to mimic in vivo conditions and tumor microenvironment is insufficient
Solution Approach 1:
The device is divided into multiple functional segments including a flow channel for immune cell perfusion, reservoirs for GBM tumor culture, and barriers to create distinct microenvironmental zones. This segmentation allows each region to maintain specific physiological conditions while enabling controlled cell-cell interactions, thereby improving in vivo condition mimicry without requiring a completely complex monolithic structure
Solution Approach 2:
The patent introduces an endothelial cell monolayer as an intermediary component between the flow channel and reservoirs. This intermediary layer mimics the blood-brain barrier and facilitates realistic immune cell migration and interaction with GBM tumors, enhancing physiological relevance while using a well-established cell culture technique rather than requiring entirely new complex structures
2Adaptability or versatility
If a microfluidic assay device with multiple components is used, then the ability to study GBM-immune cell interactions is improved, but the device complexity increases
Solution Approach 1:
The flow channel serves multiple functions: it perfuses immune cells to the tumor site, establishes physiological flow conditions to mimic blood circulation, and provides a pathway for cell migration. The barriers simultaneously create semipermeable interfaces and enable cell migration. This multi-functionality allows comprehensive study of GBM-immune cell interactions while avoiding the need for numerous separate components
Solution Approach 2:
The device employs a nested structure where reservoirs containing GBM tumors are positioned within or adjacent to the flow channel system, and endothelial cell monolayers are cultured within the flow channel to line the pathway. This nesting allows multiple cell types and functional zones to occupy a compact space, enabling versatile interaction studies without proportionally increasing overall device complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Facilitates a better understanding of GBM-immune cell interactions, providing insights for developing targeted immunotherapies against GBM by mimicking the tumor microenvironment and blood-brain barrier.
Implementation Method 1
a plurality of barriers arranged along the interface of the flow channel with each reservoir; the plurality of barriers configured to provide a semipermeable interface
Data Source
AI summary
Described herein is a microfluidic assay device that mimics in vitro the in vivo biological environment, supporting endothelization, allowing for perfusive flow similar to in vivo blood flow conditions, and providing for realistic interactions between T-cells and solid tumor cells, such as glioblastoma multiforme tumor cells. Also described herein are methods of using this microfluidic assay device for the study of interactions of immune cells with tumor cells, such as glioblastoma multiforme tumor cells, and the development of improved immunotherapeutic approaches against cancers, such as glioblastoma multiforme.